This Week’s Top Headlines Pfizer Releases Biosimilar Data, Rivals J&J Posted 2/22/17 At the six-week mark of its fifty-four-week study, Pfizer released data for its biosimilar, Inflectra as a treatment for Crohn’s disease. Previously, Inflectra was approved...
5th Semi-Annual Medical Device Supplier Quality Conference Speaker Interview: Joerg Pantermoller Director of Supplier Quality Management BIOTRONIK Currently engaged as the Director of Supplier Quality Management at BIOTRONIK, with global responsibility for suppliers...
At the six-week mark of its fifty-four-week study, Pfizer released data for its biosimilar, Inflectra as a treatment for Crohn’s disease. Previously, Inflectra was approved to treat moderate to severe Crohn’s disease but did not have Crohn’s-specific data. With its...
Biotronik has received FDA approval for its first bare-metal stent for coronary arteries. The device is intended for patients with new and recurring blockages in the coronary arteries between 2.25 and 4.0 mm in diameter and lesion lengths up to 31 mm. The PRO-Kinetic...
Due to cost, efficiency, and shorter time frames, many companies have begun printing prosthetics. The devices, used among children and adults alike, have found niche markets in underprivileged countries as the cost of traditional prosthetics rises. Many are claiming...
